<DOC>
	<DOCNO>NCT00773409</DOCNO>
	<brief_summary>The objective long term study prospectively evaluate incidence NSF patient severe CKD kidney failure include patient undergoing dialysis ( stag 4 5 i.e. , eGFR 30 ) exposure GBCA within 10 year prior enrollment .</brief_summary>
	<brief_title>Evaluation Risk Nephrogenic Systemic Fibrosis ( NSF ) Patients With Chronic Kidney Disease Without Exposure Gadolinium Based Contrast Agents ( GBCA )</brief_title>
	<detailed_description />
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Renal Insufficiency , Chronic</mesh_term>
	<mesh_term>Renal Insufficiency</mesh_term>
	<mesh_term>Nephrogenic Fibrosing Dermopathy</mesh_term>
	<criteria>Has CKD eGFR 30 mL/min/1.73m2 and/or undergoing dialysis calculate serum creatinine ( SCr ) value obtain local laboratory within 24 hour prior sign informed consent ; Provides write informed consent willing comply protocol requirement Has receive GBCA within past 10 year prior inclusion study include administration GBCA something MRI ( e.g. , CT DSA ) ; Has medical condition circumstance would significantly decrease chance obtain reliable data achieve study objective ; Has ever suspect , diagnose , NSF ; Is unable unwilling return necessary office visit , examine dermatologist undergo deep skin biopsy laboratory/other diagnostic evaluation development NSF suspect .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2012</verification_date>
</DOC>